PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Wednesday, 01 April 2020

The Authority wishes to notify stakeholders of the introduction of the MCAZ electronic Clinical Trials application and registry system (e-CTR System).

This system allows investigators to submit applications for authorisation of clinical trials to MCAZ, to view the progress of the applications in real-time and to respond to queries raised. This system can be accessed using the link below:

e-Clinical Trials Submission

 

After the clinical trial has been authorised, the system also allows investigators to submit SAE reports, protocol amendments, protocol deviations, progress reports and any other notifications or post-authorisation applications to MCAZ. The list of clinical trials authorisation by MCAZ from August 2019 onwards can be viewed using the link provided below:

Publicc Clinical Trials Registry

 

Clinical trials are defined as a systematic study in human beings or animals inorder to establish the efficacy of, or to discover or verify the effects or adverse reactions of medicines, and includes a study of the absorption, distribution, metabolism and excretion of medicines.

All clinical trials that are conducted in Zimbabwe are regulated in terms of Part III of the Medicines and Allied Substances Control Act [Chapter 15:03] and its regulations. In terms of the Act, no person shall conduct a clinical trial of any medicine without the prior written authorisation of the Authority, granted with the approval of the Secretary of the Ministry of Health and Child Welfare.

The guidelines for Good Clinical Practice have been updated. You will find the new guidelines on the Downloads page. The file is entitled "Guidelines for GCP 2012 Zimbabwe", it replaces "Zimbabwe Guidelines for good clinical trial practice", which has been removed from this website.
 

 

 

Latest News

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Medicines Information Bulletin - 2019

20 December 2019
Medicines Information Bulletin - 2019

Inside this issue: E-Reporting Tools Safety Notifications for Fluoroquinolones and Quinolones Antibiotics Notification of a potential risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) in patients treated...

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...

Draft Guidelines For Comments Only: Guideline for Submitting Application for Variations to Registered Medicines

17 May 2019
Draft Guidelines For Comments Only: Guideline for Submitting Application for Variations to Registered Medicines

In line with the WHO guidelines on variations and other SRA guidelines, the EVR Division is updating the MCAZ Guidelines for submitting applications for Variations to Registered Medicines. The update...

Careers @ MCAZ

30 October 2018

The Medicines Control Authority of Zimbabwe (MCAZ) is inviting suitably qualified, honest, self-motivated applicants for the following post: REGULATORY OFFICER x1 POST - LICENSING AND ENFORCEMENT DIVISION Reporting to the...

Fellowship in regulatory science for African Medicine Reviewers/Assessors

26 October 2018
Fellowship in regulatory science for African Medicine Reviewers/Assessors

  Background   The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence (ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership (EDCTP) is offering...

Quality Policy Statement

06 July 2018
Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...

MCAZ Newsletter

10 May 2018
MCAZ Newsletter

In this issue: MCAZ turns 20 years Basics of reporting Side Effects of medicines Electronic Adverse Drug Reaction Reporting   For more information Please click here to download the Newsletter...

Medicines Information Bulletin - 2018

02 February 2018
Medicines Information Bulletin - 2018

Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download the 2018 Drug Information Bulletin